accountthe anticipated Docetaxel sales tally shifted into the first quarter from the second quarter. Hospira, spun off from Abbott Laboratories (ABT) in 2004, reported a first-quarter profit of $149.9 million, or 88 cents a share, up from $141.7 million, or 84...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Hospira profit rises 5.8% absent year-ago charges
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account